Summary of recommendations: Guidelines for the Prevention of Intravascular Catheter-related Infections.

TY - JOUR

T1 - Summary of recommendations

T2 - Guidelines for the Prevention of Intravascular Catheter-related Infections.

AU - O'Grady, Naomi P.

AU - Alexander, Mary

AU - Burns, Lillian A.

AU - Dellinger, E. Patchen

AU - Garland, Jeffrey

AU - Heard, Stephen O.

AU - Lipsett, Pamela A.

AU - Masur, Henry

AU - Mermel, Leonard A.

AU - Pearson, Michele L.

AU - Raad, Issam I.

AU - Randolph, Adrienne G.

AU - Rupp, Mark E.

AU - Saint, Sanjay

AU - Healthcare Infection Control Practices Advisory Committee (HICPAC) (Appendix 1), Infection Control Practices Advisory Committee (HICPAC) (Appendix 1)

N1 - Funding Information: Notice to Readers. In 2009, the Centers for Disease Control and Prevention (CDC) and Healthcare Infection Control Practices Advisory Committee (HICPAC) integrated current advances in guideline production and implementation into its development process (http://www.cdc.gov/ hicpac/guidelineMethod/guidelineMethod. html). The new methodology enables CDC and HICPAC to improve the validity and usability of its guidelines while also addressing emerging challenges in guideline development in the area of infection prevention and control. However, the Guidelines for the Prevention of Intravascular Catheter-Related Infections were initiated before the methodology was revised. Therefore, this guideline reflects the development methods that were used for guidelines produced prior to 2009. Future revisions will be performed using the updated methodology. Financial support. E.P.D. Grant support through the NIH. Funding Information: Potential conflicts of interest. N.P.O.’G. served as a board member for the ABIM Subspecialty Board for Critical Care Medicine. M.A. is an employee of the Infusion Nurses Society, Honoraria from 3M, Becton Dickinson, Smiths Medical. L.A.B. is a consultant for Institute of Healthcare Improvement, Board membership for Theradoc, Medline. Honoraria from APIC, Clorox. E.P.D. consulting from Merck, Baxter, Ortho-McNeil, Targanta, Schering-Plough, Optimer, Cadence, Cardinal, BDGeneOhm, WebEx, Cerebrio, and Tyco. Grant support through the NIH. Payment for lecture from Merck. Payment for development of educational presentation from Medscape. Travel and meeting expenses paid for by ASHP, IDSA, ASM, American College of Surgeons, NQF, SHEA/CDC, HHS, Trauma Shock Inflammation and Sepsis Meeting (Munich), University of Minnesota. J.G. Honoria from Ethicon. S.O.H. provides research support from Angiotech; Honoraria from Angiotech, Merck. L.A.M provides research support from Astellas, Theravance, Pfizer; Consulting for Ash Access, Cadence, CorMedix, Catheter Connections, Carefusion, Sage, Bard, Teleflex; Payment for manuscript preparation from Catheter Connections. I.I.R. provides research support from Cubist, Enzon, and Basilea;Consulting for Clorox; Stock Equity or Options in Great Lakes Pharmaceuticalsand Inventive Protocol; Speakers Bureau for Cook, Inc.; Royalty income (patents owned by MD Anderson on which Dr. Raad in an inventor: American Medical Systems, Cook, Inc., Cook urological, Teleflex, TyRx, Medtronic, Biomet, Great Lakes Pharmaceuticals. A.R. consulting income from Eisai Pharmaceuticals, Discovery Laboratories. M.E.R. provides research support from Molnlycke, Cardinal Healthcare Foundation, Sanofi-Pasteur, 3M, and Cubist; Consulting from Semprus; Honorarium for lectures from 3M, Carefusion, Baxter and Becton Dickinson. Previously served on Board of Directors for Society for Healthcare Epidemiology of America. All other authors: no conflicts.

PY - 2011/5

Y1 - 2011/5

UR - https://www.scopus.com/pages/publications/80051579218

UR - https://www.scopus.com/pages/publications/80051579218#tab=citedBy

U2 - 10.1093/cid/cir138

DO - 10.1093/cid/cir138

M3 - Article

C2 - 21467014

AN - SCOPUS:80051579218

SN - 1058-4838

VL - 52

SP - 1087

EP - 1099

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 9

ER -